第三种类型的干扰素受体的合成异构体需要TYK2来激活STAT
Emily V Mesev1, Emma G Guare1, Alexander Ploss1
1Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA.
概括
与I型干扰素不同的是,III型干扰素 (IFN-λ) 信号独立于氨酸激酶2 (TYK2). 这项研究表明,非正规的受体综合体可能会调解这种TYK2-独立的IFN-λ信号传递.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 病毒学 病毒学
背景情况:
- 第三类干扰素 (IFN-λ) 对于表皮屏障的抗病毒防御至关重要.
- IFN-λ和I型干扰素 (IFN-α) 通过Janus相关激酶1 (JAK1) 和氨酸激酶2 (TYK2) 使用JAK-STAT通路.
- 最近的发现表明,TYK2对于IFN-λ信号是不可或缺的,与其对于IFN-α信号的必要性形成鲜明对比.
研究的目的:
- 阐明TYK2在I型和III型干扰素信号传输中的不同要求背后的机制.
- 定义IFN-λ和IFN-α信号传输中需要TYK2.2.的特定过程.
主要方法:
- 在TYK2缺乏的U2OS上皮细胞中利用合成干扰素受体.
- 研究了来自I型和III型干扰素受体的异体和同体受体复合体的信号传递.
主要成果:
- TYK2 缺乏同样影响了 I 型和 III 型干扰素受体异构体的信号传输.
- 在没有TYK2.2.的情况下,IFNAR2或IFNLR1的JAK1关联同位素表现出完全的信号能力.
- 单独的III型IFN受体的异构化并不能赋予TYK2独立的信号.
结论:
- 对于TYK2独立的IFN-λ信号传递的机制尚不清楚.
- 建议非正规受体综合体调解内源性III型IFN信号,从而赋予TYK2独立性.
- 了解这种途径对于开发有针对性的抗病毒疗法至关重要.
更多相关视频
相关概念视频
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Receptor Tyrosine Kinases
13.1K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.1K
Enzyme-linked Receptors
78.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.7K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


